Elaine Abrams
Elaine Abrams is a global thought leader in the prevention and treatment of HIV infection and associated infectious diseases in pregnant women, children, and families. A professor of epidemiology and pediatrics at Columbia University, she was a founding member of ICAP at Columbia University. As part of ICAP’s core leadership team, Abrams is senior research director, supporting ICAP’s global research with a growing portfolio of studies of HIV and TB prevention, care, and treatment. As an independently funded research scientist, Abrams also leads a number of studies optimizing HIV treatment and prevention across the life course for women during pregnancy and breastfeeding and for infants, children, and adolescents. Abrams’s expertise guides both US and global HIV policy and implementation planning through many avenues such as scientific leadership in the NIH-funded IMPAACT network, the World Health Organization Pediatric Antiretroviral and Pregnancy Working Groups. Abrams has worked in perinatal and pediatric HIV prevention and treatment for over 30 years as a clinician, researcher, and public health practitioner. She has extensive experience in the design, implementation, and analysis of antiretroviral treatment studies of pregnant/postpartum women, infants, and children and has studied HIV prevention and treatment across the maternal-child lifecycle. Her work has led to important insights on interplay of structural, behavioral, and biomedical factors influencing retention, adherence, and ART efficacy during pregnancy, childhood, and adolescence.
Biography current as of January 2023